The facility will initially manufacture medications in vial form, with future plans to produce sterile injectables in syringes. This is the first U.S. FDA approval for the Indore facility.

EOO conceived the study, EOO, MU carried out the study. ACY transferred all data received from clinic to SPSS and EXCEL and performed all statistical analyses. EOO, MU and ACY participated in ...

The site is expected to eventually produce medicines in syringes, in addition to vials. This is the Indore facility's first US FDA approval. Endo plans to apply for additional product approvals at the ...

the type of irrigation regimen, treatment modality and the number of visits, in patients who received root canal treatment from January 2002 to January 2008. Methods: Records of 1819 teeth ...

The cannabidiol (CBD) world can feel huge and complicated, but products like CBD gummies make it more approachable for some folks. CBD gummies are easy to dose, portable, and discreet. They also ...

TOKYO -- Japan is not making progress in vaccinations against the HPV, which causes cervical cancer. As of January 2024, the HPV vaccine had been introduced into national immunization programs in ...